This year's winter COVID-19 wave is off to a late start, and experts expect cases to keep rising. Here's what to know.

BioNTech has entered into two separate settlement agreements with the U.S. National Institutes of Health and the University ...

Here are four drug and biotech stocks, ARQT, MESO, MNPR and KOD, which have more than doubled in 2024 with room for further ...

Tokyo-headquartered pharmaceutical company, Meiji Seika Pharma has filed a lawsuit against Kazuhiro Haraguchi, a Lower House member of Japan’s Constitutional Democratic Party, for reportedly spreading ...

With these pressures, public health has no choice but to adapt. Although new technologies like mRNA vaccine platforms and at-home testing are expanding our arsenal against outbreaks, we cannot rely ...

The global response to the COVID-19 pandemic has been characterized by a massive rollout of vaccines aimed at curbing the ...

“I just left Wayne Gretzky, ‘The Great One’ as he is known in Ice Hockey circles,” Trump posted on Truth Social. “I said, ‘Wayne, why don’t you run for Prime Minister of Canada, soon to be known as ...

This article discusses the risk and opportunities of six major constituents of PJP ETF: Pfizer, Amgen, Gilead, AbbVie, BMY, ...

This year's winter COVID-19 wave is off to a late start, and experts expect cases to keep rising. Here's what to know.

With breakthroughs from melanoma to pancreatic cancer, this has been a year of great promise in the field of cancer vaccines.

A Fremont pharmaceutical company received an investment of approximately $50 million in a private placement from Merck & Co.

The WHO Technical Advisory Group on COVID-19 Vaccine Composition (TAG-CO-VAC) continues to closely monitor the genetic and antigenic evolution of SARS-CoV-2 variants, immune responses to SARS-CoV-2 ...